Literature DB >> 2304145

Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen.

H Okamoto1, S Yotsumoto, Y Akahane, T Yamanaka, Y Miyazaki, Y Sugai, F Tsuda, T Tanaka, Y Miyakawa, M Mayumi.   

Abstract

The C gene of hepatitis B virus (HBV) codes for a nucleocapsid protein made of 183 amino acid residues and is preceded in phase by the precore (pre-C) region, encoding 29 residues. The pre-C-region product is required for the synthesis and secretion of hepatitis B e antigen (HBeAg), which is made of the C-terminal 10 amino acid residues of the pre-C-region product and the N-terminal 149 residues of the C-gene product. HBV mutants with pre-C-region defects prevailed in the circulation of three asymptomatic carriers as they seroconverted from HBeAg to the corresponding antibody (anti-HBe), and these mutants finally replaced nondefective HBV. HBV DNA clones were propagated from sera of an additional 15 carriers with anti-HBe and sequenced for the pre-C region. Essentially all HBV DNA clones (56 of 57 [98%]) revealed mutations that prohibited the translation of a functional pre-C-region product. A point mutation from G to A at nucleotide 83, converting Trp-28 (TGG) to a stop codon (TAG), was by far the commonest and was observed in HBV DNA clones from 16 (89%) of 18 carriers seropositive for anti-HBe. In addition, there were point mutations involving ATG codon to abort the translation initiation of the pre-C region, as well as deletion and insertion to induce frameshifts. Such mutations leading to pre-C-region defects were rarely observed in persistently infected individuals positive for HBeAg or in patients with type B acute hepatitis after they had seroconverted to anti-HBe. These results would indicate a selection of pre-C-defective mutants in persistently infected hosts, along with seroconversion to anti-HBe, by immune elimination of hepatocytes harboring nondefective HBV with the expression of HBeAg.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304145      PMCID: PMC249247     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Demonstration of hepatitis B e antigen in the core of Dane particles.

Authors:  K Takahashi; Y Akahane; T Gotanda; T Mishiro; M Imai; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

2.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

4.  Murine cells carrying integrated tandem genomes of hepatitis B virus DNA transcribe RNAs from endogenous promoters on both viral strands and express middle and major viral envelope proteins.

Authors:  A Z Zelent; M A Sells; P M Price; A Mohamad; G Acs; J K Christman
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr.

Authors:  H Okamoto; M Imai; F Tsuda; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication.

Authors:  C Chang; G Enders; R Sprengel; N Peters; H E Varmus; D Ganem
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

7.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

8.  Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes.

Authors:  H Okamoto; M Imai; M Shimozaki; Y Hoshi; H Iizuka; T Gotanda; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

9.  The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation.

Authors:  H J Schlicht; J Salfeld; H Schaller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  81 in total

1.  Early mutation of precore (A1896) region prior to core promoter region mutation leads to decrease of HBV replication and remission of hepatic inflammation.

Authors:  Y Karino; J Toyota; T Sato; T Ohmura; K Yamazaki; T Suga; K Nakamura; M Sugawara; T Matsushima; K Hino
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.

Authors:  Li Zong; Yanli Qin; Haodi Jia; Lei Ye; Yongxiang Wang; Jiming Zhang; Jack R Wands; Shuping Tong; Jisu Li
Journal:  Virology       Date:  2017-03-03       Impact factor: 3.616

3.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

4.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

5.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.

Authors:  T Karasawa; T Shirasawa; Y Okawa; A Kuramoto; N Shimada; Y Aizawa; M Zeniya; G Toda
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

7.  High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter.

Authors:  Xiao-Mou Peng; Gui-Mei Huang; Jian-Guo Li; Yang-Su Huang; Yong-Yu Mei; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

8.  Synergistic effects of A1896, T1653 and T1762/A1764 mutations in genotype c2 hepatitis B virus on development of hepatocellular carcinoma.

Authors:  H Lyu; D Lee; Y-H Chung; J A Kim; J-H Lee; Y-J Jin; W Park; P Mathews; E Jaffee; L Zheng; E Yu; Y J Lee
Journal:  J Viral Hepat       Date:  2012-08-16       Impact factor: 3.728

9.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.

Authors:  A Nagasaka; S Hige; M Marutani; I Tsunematsu; M Saito; Y Yamamoto; S Konishi; M Asaka
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.